u/Additional_Spell455 · 364d agono track record yet
“Just got in with a decent position”
$FEMY, might be worth keeping an eye on🚀
Femasys has secured CE Mark approval for FemBloc, its first non-surgical permanent birth control system, with early European orders and U.S. FDA trials underway. Multiple near-term catalysts (revenue updates, European launches, clinical readouts) combined with recent $8M financing and Russell Microcap inclusion position this microcap for potential significant upside as products reach market.
At post $12.60Now $2.04-83.8% since posted26m ago
1d—
3d+33.2%
1w-2.7%
1m+1.1%
3m-8.6%
6m-33.8%
1y—